Telehealth in Lewy Body Dementia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Florida

About this trial

Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.

Eligibility criteria

Qualifiers

LBD diagnosis by a dementia or movement disorders specialist

Clinician-determined mild-moderate dementia severity

Internet access with a Zoom-compatible device

Caregiver who resides in the patient's home and is willing to participate

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Tele-neurohub

Treatment groups

106 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Florida

Lead sponsor

National Institute on Aging (NIA)

Collaborator